Srs Capital Advisors, Inc. Astrazeneca PLC Transaction History

Srs Capital Advisors, Inc.

$901 Million
Q1 2024

A detailed history of Srs Capital Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 2,546 shares of AZN stock, worth $195,201. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,546

Previous 2,602 2.15%

Holding current value

$195,201

Previous $175,000 1.71%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $3,417 - $3,895	-56 Reduced 2.15%	2,546 $172,000
Q4 2023 Feb 06, 2024	BUY	$61.89 - $69.28 $64,303 - $71,981	1,039 Added 66.47%	2,602 $175,000
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $3,566 - $3,943	55 Added 3.65%	1,563 $105,000
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $4,963 - $5,382	71 Added 4.94%	1,508 $107,000
Q1 2023 May 16, 2023	BUY	$63.15 - $71.6 $7,893 - $8,950	125 Added 9.53%	1,437 $99,000

Q4 2022 Feb 24, 2023	SELL	$54.21 - $70.44 $8,565 - $11,129	-158 Reduced 10.75%	1,312 $88,000
Q3 2022 Nov 03, 2022	BUY	$53.02 - $135.75 $75,023 - $192,086	1,415 Added 2572.73%	1,470 $81,000
Q2 2022 Aug 22, 2022	BUY	$59.26 - $71.14 $2,607 - $3,130	44 Added 400.0%	55 $4,000
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $1,504 - $1,812	-27 Reduced 71.05%	11 $1,000
Q4 2021 Feb 08, 2022	BUY	$54.02 - $63.83 $1,458 - $1,723	27 Added 245.45%	38 $2,000
Q3 2021 Nov 05, 2021	SELL	$55.56 - $60.79 $2,389 - $2,613	-43 Reduced 79.63%	11 $1,000
Q2 2021 Aug 02, 2021	BUY	$48.42 - $60.18 $48 - $60	1 Added 1.89%	54 $3,000
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $2,812 - $3,238	53 New	53 $3,000
Q3 2018 Nov 06, 2018	SELL	$34.76 - $39.72 $45,014 - $51,437	-1,295 Closed	0 $0
Q2 2018 Aug 21, 2018	BUY	$34.55 - $37.05 $276 - $296	8 Added 0.62%	1,295 $45,000
Q1 2018 May 14, 2018	BUY	$32.97 - $36.63 $22,782 - $25,311	691 Added 115.94%	1,287 $45,000
Q4 2017 Feb 15, 2018	BUY	$32.09 - $34.78 $385 - $417	12 Added 2.05%	596 $20,000
Q3 2017 Nov 15, 2017	BUY	$28.96 - $34.0 $16,912 - $19,856	584	584 $19,000

Others Institutions Holding AZN

# of Institutions

1,250

Shares Held

477M

Call Options Held

5.99M

Put Options Held

5.24M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $238B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.

Account

Srs Capital Advisors, Inc. Astrazeneca PLC Transaction History